Form 4 for LRCX Lam Research
Accepted 2025-10-28 00:00:00 ET · period of report 2025-10-27 · accession 0001642415-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-28 | 2025-10-27 | LRCX | Harter Ava | CLO | S - Sale+OE | $157.47 | -9,010 | 56.8K | -14% | -$1.42M |
| D | 2025-10-28 | 2025-10-27 | LRCX | Harter Ava | CLO | M - OptEx | $77.04 | +6,010 | 62.8K | +11% | +$463.0K |
| D | 2025-10-28 | 2025-10-27 | LRCX | Harter Ava | CLO | M - OptEx | $0.00 | -6,010 | 12.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-27 | S | D | 6,010 | $157.46 | 56,786.46 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 2 | Common | Common Stock | 2025-10-27 | S | D | 3,000 | $157.48 | 56,786.46 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 3 | Common | Common Stock | 2025-10-27 | M | A | 6,010 | $77.04 | 62,796.46 | D | — | — | (F1) The amount reported includes shares subject to unvested restricted stock units. |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2025-10-27 | M | D | 6,010 | $0.00 | 12,020 | D | $77.04 · — to 2031-08-05 | 6,010 Common Stock | (F2) The stock options will become exercisable in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027. |